Suppr超能文献

肯尼亚 HIV 阳性妇女中人类乳头瘤病毒感染和宫颈病变的流行情况及其决定因素。

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.

机构信息

International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, Lyon, France.

出版信息

Br J Cancer. 2012 Oct 23;107(9):1624-30. doi: 10.1038/bjc.2012.441. Epub 2012 Oct 2.

Abstract

BACKGROUND

We assessed the association of human papillomavirus (HPV) infection and cervical intraepithelial neoplasia (CIN) with various characteristics, CD4 count and use of combination antiretroviral therapy (cART) among HIV-positive women.

METHODS

Cross-sectional study of 498 HIV-positive women who underwent HPV PCR-based testing, cytology, and systematic cervical biopsy.

RESULTS

In all, 68.7% of women were HPV-positive, 52.6% had high-risk (hr) HPV, and 40.2% multiple type infections. High-risk human papillomavirus-positivity did not vary significantly by age but it was negatively associated with education level. The most frequent types in 113 CIN2/3 were HPV16 (26.5%), HPV35 (19.5%), and HPV58 (12.4%). CD4 count was negatively associated with prevalence of hrHPV (P<0.001) and CIN2/3 among non-users of cART (P=0.013). Combination antiretroviral therapies users (≥2 year) had lower hrHPV prevalence (prevalence ratio (PR) vs non-users=0.77, 95% confidence interval (CI): 0.61-0.96) and multiple infections (PR=0.68, 95% CI: 0.53-0.88), but not fewer CIN2/3. The positive predictive value of hrHPV-positivity for CIN2/3 increased from 28.9% at age <35 years to 53.3% in ≥45 years.

CONCLUSION

The burden of hrHPV and CIN2/3 was high and it was related to immunosuppression level. Combination antiretroviral therapies ( ≥2 year) use had a favourable effect on hrHPV prevalence but cART in our population may have been started too late to prevent CIN2/3.

摘要

背景

我们评估了人乳头瘤病毒(HPV)感染和宫颈上皮内瘤变(CIN)与各种特征、CD4 计数以及接受联合抗逆转录病毒治疗(cART)的 HIV 阳性女性之间的关联。

方法

对 498 名接受 HPV PCR 检测、细胞学和系统宫颈活检的 HIV 阳性女性进行了横断面研究。

结果

所有女性中,68.7%的女性 HPV 阳性,52.6%的女性高危(hr)HPV 阳性,40.2%的女性多重感染。高危型 HPV 阳性率与年龄无显著差异,但与教育程度呈负相关。在 113 例 CIN2/3 中,最常见的类型是 HPV16(26.5%)、HPV35(19.5%)和 HPV58(12.4%)。CD4 计数与 hrHPV 流行率呈负相关(P<0.001),与非 cART 使用者的 CIN2/3 呈负相关(P=0.013)。cART 使用者(≥2 年)的高危 HPV 流行率较低(与非使用者相比,流行率比(PR)为 0.77,95%置信区间(CI):0.61-0.96)和多重感染(PR=0.68,95% CI:0.53-0.88),但 CIN2/3 较少。hrHPV 阳性预测值从 35 岁以下的 28.9%增加到≥45 岁的 53.3%。

结论

高危型 HPV 和 CIN2/3 的负担很重,与免疫抑制水平有关。≥2 年的 cART 治疗对高危 HPV 流行率有有利影响,但我们人群中的 cART 可能开始得太晚,无法预防 CIN2/3。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/3493776/8d13003db41f/bjc2012441f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验